User profiles for Margherita Vieri

Margherita Vieri

Verified email at ukaachen.de
Cited by 296

[HTML][HTML] Epigenetic clocks are not accelerated in COVID-19 patients

J Franzen, S Nüchtern, V Tharmapalan, M Vieri… - International Journal of …, 2021 - mdpi.com
Age is a major risk factor for severe outcome of the 2019 coronavirus disease (COVID-19). In
this study, we followed the hypothesis that particularly patients with accelerated epigenetic …

Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies

…, N Estrada, B Xicoy, S Isfort, M Vieri… - Annals of the New …, 2020 - Wiley Online Library
Assessment of telomere length (TL) in peripheral blood leukocytes is part of the diagnostic
algorithm applied to patients with acquired bone marrow failure syndromes (BMFSs) and …

Treatment of telomeropathies

M Vieri, TH Bruemmendorf, F Beier - Best Practice & Research Clinical …, 2021 - Elsevier
Telomeropathies or telomere biology disorders (TBDs) are a group of rare diseases characterised
by altered telomere maintenance. Most patients with TBDs show pathogenic variants …

[HTML][HTML] PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation

…, C Rösseler, V Tharmapalan, CC Kuo, M Vieri… - Clinical …, 2020 - Springer
Background Dyskeratosis congenita (DKC) and idiopathic aplastic anemia (AA) are bone
marrow failure syndromes that share characteristics of premature aging with severe telomere …

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL

AM Savino, J Sarno, L Trentin, M Vieri, G Fazio… - Leukemia, 2017 - nature.com
Leukemias bearing CRLF2 and JAK2 gene alterations are characterized by aberrant JAK/STAT
signaling and poor prognosis. The HDAC inhibitor givinostat/ITF2357 has been shown …

[HTML][HTML] Comparable effects of the androgen derivatives danazol, oxymetholone and nandrolone on telomerase activity in human primary hematopoietic cells from …

M Vieri, M Kirschner, M Tometten, A Abels… - International Journal of …, 2020 - mdpi.com
Dyskeratosis congenita (DKC) is a rare inherited disease of impaired telomere maintenance
that progressively leads to multi-organ failure, including the bone marrow. By enhancing …

[HTML][HTML] Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms

M Vieri, V Tharmapalan, M Kalmer, J Baumeister… - Blood Cancer …, 2023 - nature.com
Dear Editor, Myeloproliferative neoplasms (MPNs) are caused by somatic driver mutations,
such as JAK2V617F, which might also affect cellular aging and senescence. Here, we …

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

M Kirschner, M Vieri, K Kricheldorf… - British journal of …, 2021 - Wiley Online Library
Dyskeratosis Congenita (DKC) is a systemic disorder caused by mutations resulting in impaired
telomere maintenance. Clinical features include bone marrow failure and an increased …

Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL

M Bardini, L Trentin, F Rizzo, M Vieri, AM Savino… - Molecular Cancer …, 2018 - AACR
MLL-rearranged acute lymphoblastic leukemia (ALL) occurring in infants is a rare but very
aggressive leukemia, typically associated with a dismal prognosis. Despite the development …

Interstitial lung diseases associated with mutations of poly (A)‐specific ribonuclease: A multicentre retrospective study

…, MP Debray, C Gauvain, I Ba, M Vieri… - …, 2022 - Wiley Online Library
Background and objective Poly(A)‐specific ribonuclease (PARN) mutations have been
associated with familial pulmonary fibrosis. This study aims to describe the phenotype of patients …